Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry

被引:7
作者
Benedicto, Ignacio [1 ,2 ]
Molina-Jimenez, Francisca [1 ]
Moreno-Otero, Ricardo [2 ,3 ]
Lopez-Cabrera, Manuel [1 ,2 ,4 ]
Majano, Pedro L. [1 ,2 ]
机构
[1] Hosp Univ Princesa, Mol Biol Unit, Inst Invest Sanit Princesa IP, Madrid 28006, Spain
[2] Inst Salud Carlos III, CIBERehd, Madrid 28029, Spain
[3] Hosp Univ Princesa, Liver Unit, Inst Invest Sanit Princesa IP, Madrid 28006, Spain
[4] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain
关键词
Cellular polarization; Tight junctions; Lipoprotein metabolism; Hepatitis C virus; SCAVENGER RECEPTOR-BI; PRIMARY HUMAN HEPATOCYTES; SERUM AMYLOID-A; LOW-DENSITY; L-SIGN; TIGHT JUNCTIONS; EARLY STEPS; HCV ENTRY; INFECTION; CD81;
D O I
10.3748/wjg.v17.i22.2683
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) infects more than three million new individuals worldwide each year. In a high percentage of patients, acute infections become chronic, eventually progressing to fibrosis, cirrhosis, and hepatocellular carcinoma. Given the lack of effective prophylactic or therapeutic vaccines, and the limited sustained virological response rates to current therapies, new approaches are needed to prevent, control, and clear HCV infection. Entry into the host cell, being the first step of the viral cycle, is a potential target for the design of new antiviral compounds. Despite the recent discovery of the tight junction-associated proteins claudin-1 and occludin as HCV co-receptors, which is an important step towards the understanding of HCV entry, the precise mechanisms are still largely unknown. In addition, increasing evidence indicates that tools that are broadly employed to study HCV infection do not accurately reflect the real process in terms of viral particle composition and host cell phenotype. Thus, systems that more closely mimic natural infection are urgently required to elucidate the mechanisms of HCV entry, which will in turn help to design antiviral strategies against this part of the infection process. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:2683 / 2690
页数:8
相关论文
共 95 条
[1]   Characterization of low- and very-low-density hepatitis C virus RNA-containing particles [J].
André, P ;
Komurian-Pradel, F ;
Deforges, S ;
Perret, M ;
Berland, JL ;
Sodoyer, M ;
Pol, S ;
Bréchot, C ;
Paranhos-Baccalà, G ;
Lotteau, V .
JOURNAL OF VIROLOGY, 2002, 76 (14) :6919-6928
[2]   Hepatitis C virus particles and lipoprotein metabolism [J].
André, P ;
Perlemuter, G ;
Budkowska, A ;
Bréchot, C ;
Lotteau, V .
SEMINARS IN LIVER DISEASE, 2005, 25 (01) :93-104
[3]   Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection [J].
Andreo, Ursula ;
Maillard, Patrick ;
Kalinina, Olga ;
Walic, Marine ;
Meurs, Eliane ;
Martinot, Michele ;
Marcellin, Patrick ;
Budkowska, Agata .
CELLULAR MICROBIOLOGY, 2007, 9 (10) :2445-2456
[4]   A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry [J].
Baldick, Carl J. ;
Wichroski, Michael J. ;
Pendri, Annapurna ;
Walsh, Ann W. ;
Fang, Jie ;
Mazzucco, Charles E. ;
Pokornowski, Kevin A. ;
Rose, Ronald E. ;
Eggers, Betsy J. ;
Hsu, Mayla ;
Zhai, Weixu ;
Zhai, Guangzhi ;
Gerritz, Samuel W. ;
Poss, Michael A. ;
Meanwell, Nicholas A. ;
Cockett, Mark I. ;
Tenney, Daniel J. .
PLOS PATHOGENS, 2010, 6 (09)
[5]   Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction [J].
Barth, Heidi ;
Schnober, Eva K. ;
Zhang, Fuming ;
Linhardt, Robert J. ;
Depla, Erik ;
Boson, Bertrand ;
Cosset, Francois-Loic ;
Patel, Arvind H. ;
Blum, Hubert E. ;
Baumert, Thomas F. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10579-10590
[6]   Hepatitis C virus entry: Molecular biology and clinical implications [J].
Barth, Heidi ;
Liang, T. Jake ;
Baumert, Thomas F. .
HEPATOLOGY, 2006, 44 (03) :527-535
[7]   An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies [J].
Bartosch, B ;
Verney, G ;
Dreux, M ;
Donot, P ;
Morice, Y ;
Penin, F ;
Pawlotsky, JM ;
Lavillette, D ;
Cosset, FL .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8217-8229
[8]   Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor [J].
Bartosch, B ;
Vitelli, A ;
Granier, C ;
Goujon, C ;
Dubuisson, J ;
Pascale, S ;
Scarselli, E ;
Cortese, R ;
Nicosia, A ;
Cosset, FL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :41624-41630
[9]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[10]   Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells [J].
Basu, Arnab ;
Kanda, Tatsuo ;
Beyene, Aster ;
Saito, Kousuke ;
Meyer, Keith ;
Ray, Ranjit .
JOURNAL OF VIROLOGY, 2007, 81 (08) :3933-3941